CLASS II Device recall · Reported 4 Nov 2020 · FDA Enforcement Report

Merge LIS recalled by Merge Healthcare

Merge Healthcare is recalling Merge LIS, distributed in 15 states. The recall was initiated on 23 Jan 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesMerge LIS versions 4.0.1, 4.1, 4.1.1, 4.1.2, 4.1.3, 4.1.4, 4.1.5, 4.1.5 Patch 1, and 4.1.5 Patch 2
Quantity recalled47 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0289-2021
FDA event ID
86449
Recalling firm
Merge Healthcare, Hartland, WI
Classification
Class II
Status
Terminated
Recall initiated
23 Jan 2017
FDA classified
23 Oct 2020
Reported
4 Nov 2020
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Device Malfunction

Timeline

23 Jan 2017Recall initiated by company
23 Oct 2020Classified by FDA+1369 days
4 Nov 2020Published in enforcement report+12 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

A defect in the software resulted in medications that are not associated with the patient (i.e., medications that the patient is not currently taking) appearing on their report.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Merge LIS

Where it was distributed

Domestic Distribution Only: Alabama, California, Colorado, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Michigan, Mississippi, Oklahoma, Tennessee, Texas.

AlabamaCaliforniaColoradoConnecticutFloridaGeorgiaIllinoisKentuckyLouisianaMarylandMichiganMississippiOklahomaTennesseeTexas

Questions about this recall

Why was it recalled?

A defect in the software resulted in medications that are not associated with the patient (i.e., medications that the patient is not currently taking) appearing on their report.

Which lots are affected?

Merge LIS versions 4.0.1, 4.1, 4.1.1, 4.1.2, 4.1.3, 4.1.4, 4.1.5, 4.1.5 Patch 1, and 4.1.5 Patch 2

Where was it sold?

Domestic Distribution Only: Alabama, California, Colorado, Connecticut, Florida, Georgia, Illinois, Kentucky, Louisiana, Maryland, Michigan, Mississippi, Oklahoma, Tennessee, Texas.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Merge Healthcare

All 96

Other Other Medical Devices recalls

All 13,908